Cargando…
Performance evaluation of the PelvoCheck CT/NG test kit for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae
OBJECTIVE: Assessment of the performance of the PelvoCheck CT/NG test (Greiner-Bio-One GmbH) to detect Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) in first-void urine (FVU) of females. DESIGN: A cross-sectional study to compare the PelvoCheck CT/NG with COBAS TaqMan CT Test V.2.0 (Roch...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716231/ https://www.ncbi.nlm.nih.gov/pubmed/26729391 http://dx.doi.org/10.1136/bmjopen-2015-009894 |
_version_ | 1782410527879725056 |
---|---|
author | Meyer, Thomas Klos, Christian Kofler, Regina Kilic, Annett Hänel, Kristina |
author_facet | Meyer, Thomas Klos, Christian Kofler, Regina Kilic, Annett Hänel, Kristina |
author_sort | Meyer, Thomas |
collection | PubMed |
description | OBJECTIVE: Assessment of the performance of the PelvoCheck CT/NG test (Greiner-Bio-One GmbH) to detect Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) in first-void urine (FVU) of females. DESIGN: A cross-sectional study to compare the PelvoCheck CT/NG with COBAS TaqMan CT Test V.2.0 (Roche) for the detection of CT and with an in-house porA-based PCR for the detection of NG in FVU specimens. In addition, pools of 5 FVU specimens containing only CT-negative or 1 CT-positive and 4 CT-negative samples were tested. Abbott RealTime CT/NG was used as an additional test to resolve discordant results. SETTING: Samples sent from six laboratories were tested at the University Medical Center Hamburg. PARTICIPANTS: Urine samples were from 1622 female patients attending gynaecological practices for chlamydia screening, another 120 urine samples were from patients pretested for NG at Synlab, Medical Service Center, Weiden GmbH. In addition, 50 urine samples spiked with various concentrations of reference material were used. RESULTS: For the detection of CT and NG, the sensitivity and specificity of the PelvoCheck CT/NG test were 98.8% and 100%, and 98.3% and 98.2%, respectively. The data obtained with the PelvoCheck CT/NG for pooled urine specimens resulted in a positive agreement of 90.9% and a negative agreement of 100%. CONCLUSIONS: The PelvoCheck CT/NG assay is a suitable test method for the detection of CT and NG in female FVU samples, with sensitivity and specificity comparable with other Food and Drug Administration approved CT/NG nucleic acid amplification tests. To the best of our knowledge, this is the first commercial test system validated for the analysis of pooled urine specimens. No false-positive or invalid result was observed in 55 analysed pools. Nevertheless, 5 samples were false negative due to a target concentration below the limit of detection of the PelvoCheck CT/NG test as a consequence of pooling-associated dilution. |
format | Online Article Text |
id | pubmed-4716231 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-47162312016-01-31 Performance evaluation of the PelvoCheck CT/NG test kit for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae Meyer, Thomas Klos, Christian Kofler, Regina Kilic, Annett Hänel, Kristina BMJ Open Diagnostics OBJECTIVE: Assessment of the performance of the PelvoCheck CT/NG test (Greiner-Bio-One GmbH) to detect Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) in first-void urine (FVU) of females. DESIGN: A cross-sectional study to compare the PelvoCheck CT/NG with COBAS TaqMan CT Test V.2.0 (Roche) for the detection of CT and with an in-house porA-based PCR for the detection of NG in FVU specimens. In addition, pools of 5 FVU specimens containing only CT-negative or 1 CT-positive and 4 CT-negative samples were tested. Abbott RealTime CT/NG was used as an additional test to resolve discordant results. SETTING: Samples sent from six laboratories were tested at the University Medical Center Hamburg. PARTICIPANTS: Urine samples were from 1622 female patients attending gynaecological practices for chlamydia screening, another 120 urine samples were from patients pretested for NG at Synlab, Medical Service Center, Weiden GmbH. In addition, 50 urine samples spiked with various concentrations of reference material were used. RESULTS: For the detection of CT and NG, the sensitivity and specificity of the PelvoCheck CT/NG test were 98.8% and 100%, and 98.3% and 98.2%, respectively. The data obtained with the PelvoCheck CT/NG for pooled urine specimens resulted in a positive agreement of 90.9% and a negative agreement of 100%. CONCLUSIONS: The PelvoCheck CT/NG assay is a suitable test method for the detection of CT and NG in female FVU samples, with sensitivity and specificity comparable with other Food and Drug Administration approved CT/NG nucleic acid amplification tests. To the best of our knowledge, this is the first commercial test system validated for the analysis of pooled urine specimens. No false-positive or invalid result was observed in 55 analysed pools. Nevertheless, 5 samples were false negative due to a target concentration below the limit of detection of the PelvoCheck CT/NG test as a consequence of pooling-associated dilution. BMJ Publishing Group 2016-01-04 /pmc/articles/PMC4716231/ /pubmed/26729391 http://dx.doi.org/10.1136/bmjopen-2015-009894 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Diagnostics Meyer, Thomas Klos, Christian Kofler, Regina Kilic, Annett Hänel, Kristina Performance evaluation of the PelvoCheck CT/NG test kit for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae |
title | Performance evaluation of the PelvoCheck CT/NG test kit for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae |
title_full | Performance evaluation of the PelvoCheck CT/NG test kit for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae |
title_fullStr | Performance evaluation of the PelvoCheck CT/NG test kit for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae |
title_full_unstemmed | Performance evaluation of the PelvoCheck CT/NG test kit for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae |
title_short | Performance evaluation of the PelvoCheck CT/NG test kit for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae |
title_sort | performance evaluation of the pelvocheck ct/ng test kit for the detection of chlamydia trachomatis and neisseria gonorrhoeae |
topic | Diagnostics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716231/ https://www.ncbi.nlm.nih.gov/pubmed/26729391 http://dx.doi.org/10.1136/bmjopen-2015-009894 |
work_keys_str_mv | AT meyerthomas performanceevaluationofthepelvocheckctngtestkitforthedetectionofchlamydiatrachomatisandneisseriagonorrhoeae AT kloschristian performanceevaluationofthepelvocheckctngtestkitforthedetectionofchlamydiatrachomatisandneisseriagonorrhoeae AT koflerregina performanceevaluationofthepelvocheckctngtestkitforthedetectionofchlamydiatrachomatisandneisseriagonorrhoeae AT kilicannett performanceevaluationofthepelvocheckctngtestkitforthedetectionofchlamydiatrachomatisandneisseriagonorrhoeae AT hanelkristina performanceevaluationofthepelvocheckctngtestkitforthedetectionofchlamydiatrachomatisandneisseriagonorrhoeae |